Медицинская литература. Новинки

 

 

 

 

 

 

Эндоваскулярное лечение больных ишемической болезнью сердца с многососудистым поражением коронарного русла (обзор литературы)

Вы можете загрузить полный текст статьи в формате pdf

В статье рассматриваются вопросы эндоваскулярного лечения больных ишемической болезнью сердца (ИБС). Прослеживаются тенденции лечения больных ИБС от баллонной коронарной ангиопластики до эндоваскулярного стентирования непокрытыми стентами и стентами с лекарственным покрытием; от лечения больных с однососудистым поражением до многососудистых поражений. Также в статье освещаются вопросы, связанные с использованием внутрисосудистого УЗИ, используемого для уточнения состояния коронарного русла на диагностическом этапе и для оценки и оптимизации результатов операций эндоваскулярной реваскуляризации миокарда.

Ключевые слова:
аортокоронарное шунтирование, баллонная коронарная ангиопластика, внутрисосудистое УЗИ, ишемическая болезнь сердца, инфаркт миокарда, коронарная ангиография, стенты.

Литература:
1. Gruentzig A.R., Senning A., Siegenthaler W.E. et al.
Nonoperative dilatation of coronary artery stenosis; percutaneus translumenal coronary angioplasty. N. Engl. J.
Med. 1979; 301: 61–68.
2. Gruentzig A. Transluminal dilatation of coronary – artery
stenosis. Lancet 1978; 1: 263.
3. Самко А.Н., Савченко А.П. Некоторые современные
направления коронарной ангиопластики. Кардиология 1993; 9: 62–67.
4. Савченко А.П., Самко А.Н. Применение интракоронарных стентов для лечения больных ИБС. Визуализация
в клинике 1996; 8: 17–21.
5. Clark D. Coronary angioplasty. 2nd edition. New York;
1991. 105–133.
6. Smith S.C., Dove J.T., Jacobs A.K. et al. ACC/AHA
Guidelines for Percutaneus Coronary Intervention
(Revision of the 1993 PTCA Guidelines). J. Am. Coll.
Cardiol. 2001; 37: 2239i–2239xvi.
7. Smith S.C., Feldman T.E., Hirsgfeld J. W. et al. ACC/AHA/
SCAI 2005 Guideline Update for Percutaneus Coronary
Intervention. J. Am. Coll. Cardiol. 2008; 51: 172–209.
8. Алекян Б.Г., Бузиашвили Ю.И., Голухова Е.З. и др.
Стентирование коронарных артерий в лечении больных ишемической болезнью сердца. Грудная и сердечно-сосуд. хир. 1999; 6: 143–152.
9. Алекян Б.Г., Стаферов А.В Коронарное стентирование.
В кн.: Интервенционные методы лечения ишемической болезни сердца; Под ред. Л.А. Бокерия, Б.Г. Алекяна. А. Коломбо, Ю.И. Бузиашвили. М.: Издво НЦССХ
им. А.Н. Бакулева РАМН; 2002. 226–261.
10. Бабунашвили А.М., Иванов В.А., Дундуа Д.П. и др.
Лечение коронарного атеросклероза: влияние массового применения стентов на отдаленные результаты
ангиопластики. Кардиология 2004; 5: 23–29.
11. Hoffmann R., Mintz G.S. Coronary instent restenosis predictors, treatment and prevention. Eur. Heart J. 2000;
21: 1739–1749.
12. King S.B., Smith S.C., Hirshfeld J.W. et al. 2007 Focused
Update of the ACC/AHA/SCAI 2005 Guideline Update for
Percutaneous Coronary Intervention. Catheterization and
Cardiovascular Interventions. J. Am. Coll. Cardiol. 2007;
71: E1–E40.
13. Murphy J.G. A monk’s prayer: О Lord what is the answer to
in-stent restenosis? Commentary on the TRAPIST Study.
Eur. Heart J. 2001; 22: 1847–1849.
14. Silber S., Albrtsson P., Aviles F.F. et al. Guidelines for percutaneus coronary interventions. Eur. Heart J. 2005; 26
(8): 804–847.
15. Macaya C., Serruys P. W., Ruygrok P. et al. Continued benefit of coronary stenting versus balloon angioplasty: oneyear clinical followup of Benestent trial. J. Am. Coll.
Cardiol. 1996; 27: 255–261.
16. Serruys P. W., de Jaegere P. Kiemeneij F. et al. For the
Benestent Study Group. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients
with coronary artery disease. N. Engl. J. Med. 1994; 331:
489–495.
17. Van Hout B., van der Woude T., de Jaegere P. et al. Cost
effectiveness of stent implantation versus PTCA: the BENESTSNT experience. Sem. Intervent. Cardiol. 1996; 1:
263–268.
18. Garcia E., Serruys P.W., Dawkins K. et al. BNESTENT –
II Trial – final results of visit I: a 15day follow-up (abstr.).
Eur. Heart J. 1997; 18 (Suppl A): 350.
19. Legrand V., Serruys P.W., Emanuelsson H. et al. BENESTENT – II Trial – final result of visit II & III: a 7 month followup (abstr.). J. Am. Coll. Cardiol. 1997; 29 ( Suppl.): 170A.
20. Serruys P.W., van Hout B., Bonnier H. et al. Effectivness,
costs and costeffctiveness of a strategy of elective
heparincoated stenting compared with balloon angioplasty in selected patients with coronary artery disease:
the Benestent II Study. Lancet 1998; 352: 673–681.
21. Valgimigli M., Dawkins K., Macaya C. et al. Impact of stable
versus unstable coronary artery disease on 1year outcome
in elective patients undergoing multivessel revascularization with sirolimuseluting stents: a subanalysis of the ARTS
II trial. J. Am. Coll. Cardiol. 2007; 49 (4): 431–441.
22. Kukreja N., Serruys P.W., de Bruyne B. et al. Sirolimuseluting stents, bare metal stents or coronary artery bypass
grafting for patients with multivessel disease including involvement of the proximal left anterior descending
artery: analysis of the Arterial Revascularization Therapies
study part 2 (ARTSII). Heart 2009; 95 (13): 1061–1066.
23. Нueb W., Soares Р., Gersh В. et аl. The medicine, angioplasty, or surgery study (MASS – II): а randomized, controlled clinical trial of three therapeutic strategies fоr multivessel соrоnаrу artery desease. J. Аm. Соll. Cardiol.
2004; 43: 1743–1751.
24. Rodriguez A.E., Marec A.O., Grinfeld L. et al. Revascularization strategies of coronary multivessel disease in the
drug eluting stent era: one year follow-up results of the
ERACI III trial. Eur. Intervent. 2006; 2: 53–60.
25. Rodriguez A.E., Mieres J., Fernandez-Pereira C. et al.
Coronary stent thrombosis in current drug-eluting stent:
era insights from ERACI III trial. J. Am. Coll. Cardiol. 2006;
47: 205–207.
26. Rodriguez A., Bernardi V., Navia J. et al. Argentine Randomized Study: Coronary Angioplasty With Stenting Versus
Coronary Bypass Surgery in Patients With Multiple-Vessel
Disease (ERACI II): 30-day and one-year follow-up
results. ERACI II Investigators. J. Am. Coll. Cardiol. 2001;
37: 51–58.
27. Rodriguez A.E., Baldi J., Fernandez Pereira C. et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass
surgery in patients with multivessel disease (ERACI II).
J. Am. Coll. Cardiol. 2005; 46: 589–591.
28. Colombo A., Fajadet J., G. Schuler. 365day follow-up of
the RAVEL study: a randomized study with sirolimus-eluting BX Velocity balloonexpandable stent. Eur. Heart J.
2002; 4 (Suppl. A): 264.
29. Abizaid A., Costa M.A., Blanchard D. et al. Ravel investigators. Sirolimuseluting stents inkhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial. Eur.
Heart J. 2004; 25: 107–112.
30. Fajadet J., Morice M.C., Bode C. et al. Maintenance of
longterm clinical benefit with sirolimuseluting coronary
stents: threeyear results of the RAVEL trial. Circulaton
2005; 111: 1040–1044
31. Regar E., Serruys P.W., Bode C. et al. Angiographic findings of the multicenter Randomized Study With the
SirolimusEluting Bx Velocity BalloonExpandable Stent
(RAVEL): sirolimuseluting stents inhibit restenosis irrespective of the vessel size. Circulation 2002; 106: 1949.
32. Kelbaek H., Thuesen L., Helqvist S. et al. The Stenting
Coronary Arteries in Nonstress/benestent Disease
(SCANDSTENT) trial. J. Am. Coll. Cardiol. 2006; 47:
449–455.
33. Kelbaek H., Klvgaard L., Helqvist S. et al. Long-term outcome in patients treated with sirolimuseluting stents in
complex coronary artery lesions: 3year results of the
SCANDSTENT (Stenting Coronary Arteries in Non
Stress/Benestent Disease) trial. J. Am. Coll. Cardiol.
2008; 51: 2011–2016.
34. Pache J., Kastrati A., Mehilli J. et al . Sirolimus-eluting
stent or paclitaxeleluting stent vs balloon angioplasty for
prevention of recurrences in patients with coronary instent restenosis: a randomized controlled trial. J.A.M.A.
2005; 293 (2):165–171.
35. Kastrati A., Mehilli J., Pache J. et al. Analysis of 14 trials
comparing sirolimuseluting stents with baremetal
stents. N. Engl. J. Med. 2007; 356: 1030–1039.
36. Kastrati A., Dibra A., Eberle S. et al. Sirolimus-eluting
stents vs. paclitaxeleluting stents in patients with coronary artery disease: metaanalysis of randomized trials.
J.A.M.A. 2005; 294: 819–825.
37. Kastrati A., Dibra A., Spaulding C. et al. Meta-analysis of
randomized trials on drugeluting stents vs. bare-metal
stents in patients with acute myocardial infarction. Eur.
Heart J. 2006; 10: 1093.
38. Vermeersch P., Agostoni P., Verheye S. et al. DELAYED
RRISC (Death and Events at Longterm followup
AnalYsis: Extended Duration of the Reduction of
Restenosis In Saphenous vein grafts with Cypher stent)
InvestigatorsIncreased late mortality after sirolimus-eluting stents versus baremetal stents in diseased saphenous vein grafts: results from the randomized DELAYED
RRISC Trial. J. Am. Coll. Cardiol. 2007; 50 (3): 261–267.
39. Machecourt J., Danchin N., Lablanche J.M. et. al. Stents
in Diabetic and Nondiabetic Patients: The EVASTENT
matched – cohort registry. J. Am. Coll. Cardiol. 2007;
50 (6): 501–508.
40. Camenzind E., Steg P.G., Wijns W. Stent thrombosis late
after implantation of firstgeneration drugeluting stents:
a cause for concern. Circulation 2007; 115: 1440–1455.
41. McFadden E.P., Stabile E., Regar E. et al. Late thrombosis
in drugeluting coronary stents after discontinuation of
antiplatelet therapy. Lancet 2004; 364: 1519–1521.
42. Moreno R., Fernбndez C., Hernбndez R. et. al. Drug-eluting stent thrombosis results from a pooled analysis including 10 randomized studies. J. Am. Coll. Cardiol. 2005;
45: 954–959.
43. Orlich D., Bonizzoni E., Stankovic G. at el. Treatment of
multivessel coronary artery disease with sirolimus-eluting
stent implantation: immediate and midterm results.
J. Am. Coll. Cardiol. 2004; 43: 1154–1160.
44. Mintz G., Weissman N. Intravascular Ultrasound in the
DrugEluting Stent Era. J. Am. Coll. Cardiol. 2006; 48:
421–429.
45. Kotami J., Awata M., Nanto S. Incomplete neountimal coverage of sirolimuseluting stents. J. Am. Coll. Cardiol.
2006; 47: 2108–2111.
46. Farb A., Burke A.P. Pathological mechanism of fatal late
coronary stent thrombosis in humans. Circulation 2003;
108: 1701–1706.
47. Carter A.J., Aggarwal M., Kopia GA. Long-term effects
of polymerbased, slow-release, sirolimus-eluting stents
in a porcine coronary model. Cardiovasc. Res. 2004; 63:
617–624.

Endovascular Treatment of Patients with Multivessel Disease (The Literature Review)

In article questions of endovascular treatments of ischemic heart disease patients are considered. Tendencies of treatment of ischemic heart disease patients from a balloon coronary angioplasty to endovascular stenting by uncovered stents and drug eluting stents are traced; from treatment of patients with an onevascular lesion to multivessel lesions. As in article the questions bound to use of intravascular ultrasonic research, a condition of a coronary bed used for specification at a diagnostic stage and for an estimation and optimisation of results of operations endovascular myocardium revascularizations are consecrated.

Keywords:
GARB, balloon coronary angioplasty, IVUS, an ischemic heart disease, heart attack, coronary angiography, stents.